Become A Featured Company

Cannabix Continues to Build Out Intellectual Property Portfolio for Marijuana Breathalyzer technologies 

Ryan Allway

August 19th, 2021

App, Exclusive, News, Top Story

The cannabis industry has experienced significant growth over the past decade thanks to shifting consumer sentiments, legislative victories, and a growing corporate sector. At the same time, governments have struggled to keep up with regulations to protect consumers—including the safety of those that aren’t consuming any cannabis.

In the 1960s, alcohol breathalyzers became widely available to law enforcement and employers. The technology measures alcohol content by creating a chemical reaction that oxidizes the alcohol in a breath sample and produces an electrical current. And the current determines the subject’s blood alcohol content or BAC.

Cannabix Technologies Inc. (CSE: BLO, OTC: BLOZF) is developing its own breathalyzer technologies to detect tetrahydrocannabinol (THC)—the psychoactive component of the cannabis plant— in breath, to identify impaired drivers or employees that present a risk to others.

Unique Challenges for Cannabis

Fuel cell breathalyzers are ideal for roadside testing as they provide accurate readings for alcohol and are portable. Fuel cell technology is relatively simple – case in point, you can now find BAC analyzers for your keychain.  In order to accurately determine the presence of THC, law enforcement and toxicologists make use of mass spectrometry units that are large, tabletop devices typically found in a lab setting.

THC that appears in breath is typically measured in picograms (trillionths of a gram), meaning that a cannabis breathalyzer must be extremely sensitive. Cannabix leverages high-field asymmetric waveform ion mobility spectrometry (FAIMS) to detect these small concentrations in an accurate and selective manner.

Another challenge is establishing guidelines. While zero-tolerance policies are straightforward, many states have set legal limits for THC (per se limits), such as five ng/mL in Washington or one ng/mL in Pennsylvania. Unlike alcohol, there’s no real consensus about what level of THC translates to impairments on the road or the job. With this being the case, the goal is to create a portable drug screening device that can help aid law enforcement and others to help detect THC within a time period that aligns with peak impairment (a short period of 1-3 hours after cannabis use).

Building Value with Patents

Cannabix Technologies has been actively building its intellectual property portfolio over the past few years to cover innovations related to detecting THC in breath samples.

Most recently, the company announced that the U.S. PTO granted Patent No. 17/019728, entitled, “Apparatus and Methods for Detection of Molecules”. The patent is focused on the use of FAIMS innovations in detecting THC in breath samples. These developments provide utility in several areas related to the detection of target molecules in breath.

In addition to this patent, the company secured Patent No. 14/689434, entitled “Cannabis Drug Detection Device,” which was also issued by the Canadian Intellectual Property Office (CIPO). These patents provide the company with a broad foundation to build upon as they work to bring this technology to market.

Looking Ahead

Cannabix Technologies Inc. (CSE: BLO, OTC: BLOZF) is working hard to provide a reliable, fair and effective testing solution, Cannabix hopes to give law enforcement and employers the tools they currently lack to accurately determine recent marijuana use at the point of care. Combined with continued public education, such a tool could clear up a lot of the grey areas currently surrounding the issue of driving under the influence of legal cannabis and help keep our roads safer. Furthermore, technology that Cannabix is developing could ultimately make it easier for lawmakers everywhere to move forward with some form of marijuana legalization.

For more information, visit the company’s website or download their investor presentation.

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.

Network Partners

Follow Us on Social Media

LinkedIn

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading